Anti-tau antibodies targeting a conformation-dependent epitope selectively bind seeds
Brian D. Hitt, Ankit Gupta, Ruhar Singh…·Marc I. Diamond
The paper develops anti-tau antibodies that selectively bind pathological tau seeds in neurodegenerative diseases, supporting a model of conformational change at P301.